Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response. | BMC Complement Med Ther | 2023 | 37202806 | PubTator, text mining | PubMed |
| New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. | Cell Mol Immunol | 2023 | 37198402 | PubTator, text mining | PubMed |
| Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study. | BMJ Open Respir Res | 2023 | 37197795 | PubTator, text mining | PubMed |
| Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer. | Transl Lung Cancer Res | 2023 | 37197639 | PubTator, text mining | PubMed |
| Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study. | Transl Lung Cancer Res | 2023 | 37197621 | PubTator, text mining | PubMed |
| Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies. | Brain Sci | 2023 | 37190507 | PubTator, text mining | PubMed |
| Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. | Cancers (Basel) | 2023 | 37190290 | PubTator, text mining | PubMed |
| Inflammatory Networks in Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37190141 | PubTator, text mining | PubMed |
| Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 | 37188939 | PubTator, text mining | PubMed |
| Cholangiocarcinoma - novel biological insights and therapeutic strategies. | Nat Rev Clin Oncol | 2023 | 37188899 | PubTator, text mining | PubMed |
| High-level levofloxacin-resistant emm12 group A Streptococcus, 2012-2018: A multicenter study in Taiwan. | J Microbiol Immunol Infect | 2023 | 37188572 | PubTator, text mining | PubMed |
| Systemic sclerosis associated interstitial lung disease: a survey of current practices in France. | Ther Adv Musculoskelet Dis | 2023 | 37187855 | PubTator, text mining | PubMed |
| Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade. | Clin Cancer Res | 2023 | 37184976 | PubTator, text mining | PubMed |
| Tumor infiltrating lymphocytes and radiological picture of the tumor. | Med Oncol | 2023 | 37178270 | PubTator, text mining | PubMed |
| Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases. | J Clin Med | 2023 | 37176700 | PubTator, text mining | PubMed |
| Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis. | Int J Mol Sci | 2023 | 37175706 | PubTator, text mining | PubMed |
| NAMPT and PARylation Are Involved in the Pathogenesis of Atopic Dermatitis. | Int J Mol Sci | 2023 | 37175698 | PubTator, text mining | PubMed |
| The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy. | Cancers (Basel) | 2023 | 37173951 | PubTator, text mining | PubMed |
| TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. | Sci Adv | 2023 | 37172094 | PubTator, text mining | PubMed |
| Genomic analysis of 1710 surveillance-based Neisseria gonorrhoeae isolates from the USA in 2019 identifies predominant strain types and chromosomal antimicrobial-resistance determinants. | Microb Genom | 2023 | 37171855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=35